Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
GNS561 oral tablets and capsules
Locations
1
France
Genoscience Pharma
Marseille, France
Start Date
May 2, 2022
Primary Completion Date
November 30, 2022
Completion Date
November 30, 2022
Last Updated
April 29, 2022
NCT07466602
NCT06914648
NCT06766643
NCT06430983
NCT04806464
NCT05714124
Lead Sponsor
Genoscience Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions